Newcastle–Ottawa scale to evaluate the methodological quality of cohort studies included in the systematic review
First author [ref.] | |||||||
Sack [24] | Sesé [14] | Winterbottom [15] | Singh [23] | Conti [17] | Johannson [13] | Johannson [16] | |
Representativeness of the exposed cohort (patients who developed ILD or had acute exacerbations of ILD) | |||||||
Truly representative of community-based dwellers | • | • | • | • | • | • | |
Somewhat representative | |||||||
Selected group of dwellers | • | ||||||
No description of the derivation of the cohort | |||||||
Selection of the non-exposed cohort (patients who did not develop ILD or had exacerbations of ILD) | |||||||
Drawn from the same community as the exposed cohort# | • | • | • | • | • | • | • |
Drawn from a different source | |||||||
No description of the origin of the non-exposed cohort | |||||||
Ascertainment of exposure | |||||||
Secure record# | • | • | • | • | • | • | • |
Structured interview# | |||||||
Written self-report | |||||||
No description | |||||||
Demonstration that the outcome of interest was not present at start of study | |||||||
Yes# | • | • | • | • | • | • | • |
No | |||||||
Comparability of cohorts on the basis of design or analysis | |||||||
Study controls for lung diseases# | • | • | • | • | • | • | • |
Study controls for any additional factor# | • | • | • | • | • | • | • |
Assessment of outcome | |||||||
Independent blind assessment# | • | • | |||||
Record linkage# | • | • | • | • | • | ||
Self-report | |||||||
No description | |||||||
Was the follow-up long enough for outcomes to occur | |||||||
Yes# | • | • | • | • | • | • | |
No | • | ||||||
Adequacy of follow-up of the cohorts | |||||||
Complete follow-up: all subjects accounted for# | • | • | • | • | • | • | • |
Subjects lost to follow-up unlikely to introduce bias (small number lost) follow-up, or description provided of those lost# | |||||||
Low follow-up rate and no description of those lost | |||||||
No statement |
#: study satisfies the question.